Patents by Inventor Norio Unemi
Norio Unemi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 6153616Abstract: A compound of formula I, or an optical isomer or pharmaceutically acceptable salt thereof, ##STR1## is disclosed as well as a pharmaceutical composition and a method of treating or preventing a fungal infection using the compound.Type: GrantFiled: January 16, 1998Date of Patent: November 28, 2000Assignees: Synphar Laboratories, Inc., Taiho Pharmaceuticals Co., Ltd.Inventors: Mohsen Daneshtalab, Yadagiri Bathini, Dai Nguyen, Inderjit Sidhu, Mark Abel, Chan Ha, Sameeh Salama, Jehangir Khan, Ronald Micetich, Tetsuo Furukawa, Norio Unemi
-
Patent number: 5250673Abstract: Novel 2'-deoxy-5-substituted uridine derivative represented by the general formula, ##STR1## wherein R.sub.1 is a hydrogen atom, a benzoyl group or a tetrahydrofuranyl group; R.sub.2 is a fluorine atom or a trifluoromethyl group; and any one of R.sub.3 and R.sub.4 is a hydrogen atom and the other one is an alkyl group having 1 to 10 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, a benzyl group having as the substituents selected from the group consisting of a halogen atom, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms and a nitro group, or an alkyl group having 1 to 3 carbon atoms having one or two phenyl groups as the substituents.The novel 2'-deoxy-5-substituteduridine derivative possesses excellent antitumor activity with less toxicity, thus it is useful as antitumor agent.Type: GrantFiled: October 17, 1989Date of Patent: October 5, 1993Assignee: Taiho Pharmaceutical Company, Ltd.Inventors: Setsuro Fujii, Jun-ichi Yamashita, Hiroshi Matsumoto, Setsuo Takeda, Tadafumi Terada, Mitsugi Yasumoto, Norio Unemi
-
Patent number: 5032680Abstract: 2'-Deoxy-5-fluorouridine derivatives of the formula ##STR1## wherein, R.sup.1 is hydrogen atom or an acyl group and R.sup.2 and R.sup.3 are respectively hydrogen atom, an acyl group or a group of the formula ##STR2## wherein X.sup.1 and X.sup.2 are respectively oxygen atom or sulfur atom; R.sup.4 is a phenyl group, a benzyl group or a naphthyl group each of which may be substituted by an alkyl group, an alkoxyl group, an alkoxycarbonyl group, an alkylthio group, and acyl group, a halogen atom, trifluoromethyl group, nitro group, cyano group, carboxyl group and/or methylenedioxy group and R.sup.5 is an alkyl group, an alkenyl group or one of the groups represented by R.sup.4 which is the same as or different from R.sup.4, at least one of R.sup.2 and R.sup.3 being a group of the formula ##STR3## which exhibit excellent antitumour activities and have lower toxicity, methods of the production thereof and antitumour compositions containing said 2'-deoxy-5-fluorouridine derivatives.Type: GrantFiled: February 24, 1989Date of Patent: July 16, 1991Assignees: Kuraray Co., Ltd., Taiho Pharmaceutical Co., Ltd.Inventors: Tsutomu Kawai, Fumio Mori, Setsuo Takeda, Hitoshi Saito, Norio Unemi
-
Patent number: 4946951Abstract: Disclosed is a 2'-deoxy-5-fluorouridine derivative of the formula ##STR1## wherein one of R.sub.1 and R.sub.2 is a benzyl group which may optionally have substituent selected from the group consisting of C.sub.1 -C.sub.6 alkyl group, C.sub.1 -C.sub.6 alkoxy group, C.sub.1 -C.sub.3 halogenated alkyl group, halogen atom, hydroxyl group and nitro group on the phenyl ring, and the other constitutes an amino acid residue, or a salt thereof. The compounds are useful for treating cancer.Type: GrantFiled: July 29, 1988Date of Patent: August 7, 1990Assignee: Taiho Pharmaceutical Co., Ltd.Inventors: Yukio Tada, Atsuhiko Uemura, Mitsugi Yasumoto, Setsuo Takeda, Hitoshi Saito, Norio Unemi
-
Patent number: 4914105Abstract: An anti-cancer composition which comprises at least one 5-fluorouracil derivative, and a uracil derivative.Type: GrantFiled: November 20, 1986Date of Patent: April 3, 1990Inventors: Setsuro Fujii, Norio Unemi, Setsuo Takeda
-
Patent number: 4897503Abstract: This invention provides a 1,1,2-triaryl-1-butene derivative of the formula ##STR1## wherein R.sub.1 and R.sub.2 each represent a lower alkyl group, one of R.sub.3 and R.sub.4 is a lower alkyl group and the other is a group of the formula ##STR2## (in which R.sub.5 is a hydrogen atom, a lower alkyl group, a lower alkoxy group, a halogen atom or --OPO(OH).sub.2 group); or a pharmacologically acceptable salt thereof, its preparation and agents containing the derivative for treating mammary cancer and anovulatory infertility.Type: GrantFiled: January 27, 1988Date of Patent: January 30, 1990Assignee: Taiho PharmaceuticalInventors: Tetsuji Asao, Setsuo Takeda, Yoshikazu Sugimoto, Toshiyuki Toko, Yuji Yamada, Kazuo Ogawa, Norio Unemi
-
Patent number: 4886877Abstract: Novel 2'-deoxy-5-substituted uridine derivative represented by the general formula, ##STR1## wherein R.sub.1 is a hydrogen atom, a benzoyl group or a tetrahydrofuranyl group; R.sub.2 is a fluorine atom or a trifluoromethyl group; and any one of R.sub.3 and R.sub.4 is a hydrogen atom and the other one is an alkyl group having 1 to 10 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, a benzyl group having as the substituents selected from the group consisting of a halogen atom, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms and a nitro group, or an alkyl group having 1 to 3 carbon atoms having one or two phenyl groups as the substituents.The novel 2'-deoxy-5-substituteduridine derivative possesses excellent antitumor activity with less toxicity, thus it is useful as antitumor agent.Type: GrantFiled: February 26, 1988Date of Patent: December 12, 1989Assignee: Taiho Pharmaceutical Company LimitedInventors: Setsuro Fujii, Jun-ichi Yamashita, Hiroshi Matsumoto, Setsuo Takeda, Tadafumi Terada, Mitsugi Yasumoto, Norio Unemi
-
Patent number: 4719213Abstract: An anti-cancer composition for delivering a 5-fluorouracil to cancer tissues in a warm-blooded animal, wherein the cancer is a cancer sensitive to 5-fluorouracil. The composition comprises uracil or a pharmaceutically acceptable salt thereof, and a 5-fluorouracil pro drug selected from the group consisting of 1, 3-bis (2-tetrahydrofuryl)-5-fluorouracil and 3-(2-tetrahydrofuryl)-5-fluorouracil in a small amount of about 0.1 to less than 0.1 mole per mole of uracil or salt thereof.Type: GrantFiled: August 28, 1986Date of Patent: January 12, 1988Assignee: Taiho Pharmaceutical Company LimitedInventors: Setsuro Fujii, Norio Unemi, Setsuo Takeda
-
Patent number: 4652570Abstract: An anti-cancer composition for treating cancers sensitive to 5-fluorouracil therapy in warm-blooded animals, comprising 5-fluorouracil and uracil.Type: GrantFiled: August 28, 1984Date of Patent: March 24, 1987Assignee: Taiho Pharmaceutical Company, LimitedInventors: Setsuro Fujii, Norio Unemi, Setsuo Takeda
-
Patent number: 4650801Abstract: An anti-cancer composition for delivering 5-fluorouracil to cancer tissues which comprises at least one 5-fluorouracil derivative, and a uracil derivative.Type: GrantFiled: November 16, 1983Date of Patent: March 17, 1987Assignee: Taiho Pharmaceutical Company, Ltd.Inventors: Setsuro Fujii, Norio Unemi, Setsuo Takeda
-
Patent number: 4622325Abstract: An anti-cancer composition for delivering 5-fluorouracil to cancer tissues in a warm-blooded animal, wherein the cancer is a cancer sensitive to 5-fluorouracil, comprising 1-n-hexylcarbamoyl-5-fluorouracil and uracil (or salt there-of), wherein the composition contains less than 0.1 mole of the 5-fluorouracil per mole of the uracil.Type: GrantFiled: March 20, 1984Date of Patent: November 11, 1986Assignee: Taiho Pharmaceutical Company LimitedInventors: Setsuro Fujii, Norio Unemi, Setsuo Takeda
-
Patent number: 4507301Abstract: An anti-cancer composition comprising a 5-fluorouracil (including derivatives thereof) and uracil (or salt thereof), is disclosed, wherein the composition contains less than 0.1 mole of the 5-fluorouracil per mole of the uracil.Type: GrantFiled: December 8, 1980Date of Patent: March 26, 1985Assignee: Taiho Pharmaceutical Company, LimitedInventors: Setsuro Fujii, Norio Unemi, Setsuo Takeda
-
Patent number: 4481203Abstract: A composition for delivering 5-fluorouracil to cancer tissues, of a cancer sensitive to 5-fluorouracil, in warm blooded animals, comprising effective amounts of 1-(n-hexylcarbamoyl)-5-fluorouracil and uracil in a molar ratio of 1:0.1-10, respectively.Type: GrantFiled: December 3, 1980Date of Patent: November 6, 1984Assignee: Taiho Pharmaceutical Company, LimitedInventors: Setsuro Fujii, Norio Unemi, Setsuo Takeda
-
Patent number: 4371535Abstract: A composition containing a pharmacologically effective amount of 1,3-bis(2-tetrahydrofuryl)-5-fluorouracil and an excipient for delivering 5-fluorouracil to cancer cellular tissue of a cancer sensitive to 5-fluorouracil therapy.Type: GrantFiled: November 5, 1979Date of Patent: February 1, 1983Assignee: Taiho Pharmaceutical Company LimitedInventors: Norio Unemi, Kenji Kitazato, Setsuro Fujii
-
Patent number: 4328229Abstract: An anti-cancer composition comprising a 5-fluorouracil and uracil.Type: GrantFiled: February 26, 1979Date of Patent: May 4, 1982Assignee: Taiho Pharmaceutical Company LimitedInventors: Setsuro Fujii, Norio Unemi, Setsuo Takeda
-
Patent number: 4092313Abstract: A 5-fluoropyrimidin-4-one derivative represented by the formula ##STR1## wherein R is straight-chain or branched-chain alkyl having 4 to 18 carbon atoms, straight-chain or branched-chain alkenyl having 2 to 18 carbon atoms, alkylene oxido having 3 to 10 carbon atoms, aryl or aralkyl;Processes for preparing the derivative;An anti-tumor composition containing the derivative as an effective component and an excipient.Type: GrantFiled: October 6, 1976Date of Patent: May 30, 1978Assignee: Taisho Pharmaceutical Company LimitedInventors: Mitugi Yasumoto, Junichi Yamashita, Ichiro Yamawaki, Norio Unemi, Kenji Kitazato, Sadao Hashimoto, Setsuro Fujii
-
Patent number: 4080455Abstract: A 5-fluoropyrimidin-4-one derivative represented by the formula ##STR1## wherein R is straight-chain or branched-chain alkyl having 4 to 18 carbon atoms, straight-chain or branched-chain alkenyl having 2 to 18 carbon atoms, alkylene oxido having 3 to 10 carbon atoms, aryl or aralkyl;Processes for preparing the derivative;An anti-tumor composition containing the derivative as an effective component and an excipient.Type: GrantFiled: June 30, 1976Date of Patent: March 21, 1978Assignee: Taisho Pharmaceutical Company LimitedInventors: Mitugi Yasumoto, Junichi Yamashita, Ichiro Yamawaki, Norio Unemi, Kenji Kitazato, Sadao Hashimoto, Setsuro Fujii